CIK 0001743881
- Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,117,307
- in 3 filings, $5.1M under 10b5-1 plans
Net −$5,117,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award | +83,541 | 245,903 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Restricted Stock Units | +205,000 | 205,000 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +7,335 | 7,335 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +1,019 | 1,019 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +39,487 | 39,487 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +7,778 | 7,778 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +3,351 | 3,351 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +13,932 | 13,932 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +45,027 | 45,027 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +19,271 | 19,271 | ||
| 2020-05-19 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +18,365 | 18,365 | ||
| 2020-05-19 | Turtle Cameron | Grant or award · Stock Option (Right to Buy) | +1,082 | 1,082 | ||
| 2020-05-19 | Turtle Cameron | Grant or award · Stock Option (Right to Buy) | +74,042 | 74,042 | ||
| 2020-05-19 | Turtle Cameron | Grant or award · Stock Option (Right to Buy) | +49,766 | 49,766 | ||
| 2020-05-19 | Sinha Uma Chief Scientific Officer | Grant or award | +1,523 | 15,523 | ||
| 2020-05-19 | Sinha Uma Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +5,366 | 5,366 | ||
| 2020-05-19 | Sinha Uma Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +49,361 | 49,361 | ||
| 2020-05-19 | Sinha Uma Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +49,765 | 49,765 | ||
| 2020-05-19 | Sinha Uma Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +3,022 | 3,022 | ||
| 2020-05-19 | MCCORMICK FRANK Chairman of Oncology | Grant or award | +39,042 | 1,300,568 |
Page 51 of 61 · 1,201 trades